2026-2034年全球結構性心臟病器材市場規模、佔有率、趨勢和成長分析報告

預計結構性心臟器材市場將從 2025 年的 228.2 億美元成長到 2034 年的 422.3 億美元，2026 年至 2034 年的複合年成長率為 7.08%。

由於心臟瓣膜疾病病例不斷增加，全球結構性心臟植入器材市場正經歷強勁成長。這些器械用於治療結構性缺陷，無需進行開胸手術。微創手術日益普及也推動了市場擴張。

人口老化和醫療技術的進步是成長要素。診斷影像系統和設備設計的改進帶來了更好的治療效果。人們對早期診斷意識的提高以及心臟護理設施的擴建也促進了成長。

由於創新經導管器械的研發，預計未來市場將持續成長。新興市場醫療保健服務的普及將創造新的機遇，而器械的高成本和監管要求可能會限制其廣泛應用。總體而言，人們對心血管健康的日益關注將推動長期需求。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球結構性心臟病器材市場：依產品分類

• 市場分析、洞察與預測
• 生物瓣膜/組織瓣膜
• 機械心臟瓣膜
• 環狀成形術環
• 閉合裝置
• 配件

第5章：全球結構性心臟病器材市場：依手術類型分類

• 市場分析、洞察與預測
• 替代治療
• 修復治療

第6章：全球結構性心臟病器材市場：依適應症分類

• 市場分析、洞察與預測
• 瓣膜狹窄
• 瓣膜逆流
• 心肌病
• 先天性心臟疾病
• 其他

第7章：全球結構性心臟病器材市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • LivaNova Plc
  • Lepu Medical
  • Micro Interventional Devices Inc
  • LifeTech Scientific Corporation
  • Cryolife Inc

The Structural Heart Devices Market size is expected to reach USD 42.23 Billion in 2034 from USD 22.82 Billion (2025) growing at a CAGR of 7.08% during 2026-2034.

The global structural heart devices market has experienced strong growth due to rising cases of heart valve disorders. These devices are used to treat structural defects without open-heart surgery. Increasing preference for minimally invasive procedures has supported market expansion.

Major drivers include aging populations and advancements in medical technology. Improved imaging systems and device designs have enhanced treatment outcomes. Growing awareness about early diagnosis and expanding cardiac care facilities also contribute to growth.

In the future, the market is expected to grow with the development of innovative transcatheter devices. Expanding healthcare access in emerging markets will create opportunities. However, high device costs and regulatory requirements may limit adoption. Overall, rising focus on heart health will drive long-term demand.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Biological/Tissue Valves
• Mechanical Heart Valves
• Annuloplasty Rings
• Occluders
• Accessories

By Procedure

• Replacement Procedures
• Repair Procedures

By Indication

• Valve Stenosis
• Valve Regurgitation
• Cardiomyopathy
• Congenital Heart Defects
• Others

COMPANIES PROFILED

• Medtronic, Abbott, Boston Scientific Corporation, Edwards Lifesciences Corporation, LivaNova plc, Lepu Medical, Micro Interventional Devices Inc, LifeTech Scientific Corporation, Cryolife Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL STRUCTURAL HEART DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Biological/Tissue Valves Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Mechanical Heart Valves Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Annuloplasty Rings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Occluders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Accessories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL STRUCTURAL HEART DEVICES MARKET: BY PROCEDURE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Procedure
• 5.2. Replacement Procedures Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Repair Procedures Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL STRUCTURAL HEART DEVICES MARKET: BY INDICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Indication
• 6.2. Valve Stenosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Valve Regurgitation Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Cardiomyopathy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Congenital Heart Defects Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL STRUCTURAL HEART DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Procedure
  • 7.2.3 By Indication
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Procedure
  • 7.3.3 By Indication
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Procedure
  • 7.4.3 By Indication
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Procedure
  • 7.5.3 By Indication
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Procedure
  • 7.6.3 By Indication
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL STRUCTURAL HEART DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Medtronic
  • 9.2.2 Abbott
  • 9.2.3 Boston Scientific Corporation
  • 9.2.4 Edwards Lifesciences Corporation
  • 9.2.5 LivaNova Plc
  • 9.2.6 Lepu Medical
  • 9.2.7 Micro Interventional Devices Inc
  • 9.2.8 LifeTech Scientific Corporation
  • 9.2.9 Cryolife Inc